| Mechanisms underlying the action and synergism of trastuzumab and pertuzumab in targeting HER2-positive breast cancer B Nami, H Maadi, Z Wang Cancers 10 (10), 342, 2018 | 161 | 2018 |
| Genetics and expression profile of the tubulin gene superfamily in breast cancer subtypes and its relation to taxane resistance B Nami, Z Wang Cancers 10 (8), 274, 2018 | 111 | 2018 |
| HER2 in breast cancer stemness: A negative feedback loop towards trastuzumab resistance B Nami, Z Wang Cancers 9 (5), 40, 2017 | 87 | 2017 |
| The effects of trastuzumab on HER2-mediated cell signaling in CHO cells expressing human HER2 H Maadi, B Nami, J Tong, G Li, Z Wang BMC cancer 18, 1-14, 2018 | 62 | 2018 |
| Tunicamycin-induced endoplasmic reticulum stress reduces in vitro subpopulation and invasion of CD44+/CD24-phenotype breast cancer stem cells B Nami, H Donmez, N Kocak Experimental and Toxicologic Pathology 68 (7), 419-426, 2016 | 59 | 2016 |
| Titanium dioxide nanoparticles induce cytotoxicity and reduce mitotic index in human amniotic fluid-derived cells MS Acar, ZB Bulut, A Ateş, B Nami, N Koçak, B Yıldız Human & Experimental Toxicology 34 (1), 74-82, 2015 | 44 | 2015 |
| Overexpression of molecular chaperons GRP78 and GRP94 in CD44hi/CD24lo breast cancer stem cells B Nami, A Ghasemi-Dizgah, A Vaseghi BioImpacts: BI 6 (2), 105, 2016 | 42 | 2016 |
| Tarantula cubensis venom (Theranekron®) selectively destroys human cancer cells via activating caspase-3-mediated apoptosis A Ghasemi-Dizgah, B Nami, N Amirmozafari Acta Medica International 4 (1), 74-80, 2017 | 29 | 2017 |
| The effects of pertuzumab and its combination with trastuzumab on HER2 homodimerization and phosphorylation B Nami, H Maadi, Z Wang Cancers 11 (3), 375, 2019 | 28 | 2019 |
| Is methylenetetrahydrofolate reductase (MTHFR) gene A1298C polymorphism related with varicocele risk? VB Ucar, B Nami, H Acar, M Kılınç Andrologia 47 (1), 42-46, 2015 | 27 | 2015 |
| The effect of ACE2 inhibitor MLN-4760 on the interaction of SARS-CoV-2 spike protein with human ACE2: a molecular dynamics study B Nami, A Ghanaeian, K Ghanaeian, N Nami | 17 | 2020 |
| Integrated modeling of the Nexin-dynein regulatory complex reveals its regulatory mechanism A Ghanaeian, S Majhi, CL McCafferty, B Nami, CS Black, SK Yang, ... Nature Communications 14 (1), 5741, 2023 | 12 | 2023 |
| Epigenetic silencing of HER2 expression during epithelial-mesenchymal transition leads to trastuzumab resistance in breast cancer B Nami, A Ghanaeian, C Black, Z Wang Life 11 (9), 868, 2021 | 11 | 2021 |
| The interaction of the severe acute respiratory syndrome coronavirus 2 spike protein with drug-inhibited angiotensin converting enzyme 2 studied by molecular dynamics simulation B Nami, A Ghanaeian, K Ghanaeian, R Houri, N Nami, A Ghasemi-Dizgah, ... Journal of Hypertension 39 (8), 1705-1716, 2021 | 11 | 2021 |
| Genetics and Expression Profile of the Tubulin Gene Superfamily in Breast Cancer Subtypes and Its Relation to Taxane Resistance. Cancers, 2018. 10 (8) B Nami, Z Wang Epub 2018/08/22. doi: 10.3390/cancers10080274, 2018 | 9 | 2018 |
| Autophagy reduces subpopulation of CD44C/CD24/low phenotype cancer stem cells in MCF7 and Hep-2 cells culture B Nami, H Donmez, N Kocak J Cancer Stem Cell Res 3, e1002, 2015 | 8 | 2015 |
| Dimerization assessment of epithelial growth factor family of receptor tyrosine kinases by using cross-linking reagent H Maadi, B Nami, Z Wang ErbB Receptor Signaling: Methods and Protocols, 101-108, 2017 | 7 | 2017 |
| Application of Immunofluorescence Staining to Study ErbB Family of Receptor Tyrosine Kinases B Nami, Z Wang ErbB Receptor Signaling: Methods and Protocols, 109-116, 2017 | 5 | 2017 |
| Epigenetic downregulation of HER2 during EMT leads to tumor resistance to HER2-targeted therapies in breast cancer B Nami, A Ghanaeian, Z Wang bioRxiv, 2020.03. 24.006379, 2020 | 4 | 2020 |
| The Effect of ACE2 Inhibitor MLN-4760 on the Interaction of SARS-CoV-2 Spike Protein with Human ACE2: A Molecular Dynamics Study. ChemRxiv B Nami, A Ghanaeian, K Ghanaeian Preprint. https://doi. org/10.26434/chem rxiv 12159945, v1, 2020 | 4 | 2020 |
Zhixiang WangUniversity of Alberta在 ualberta.ca 的电子邮件经过验证
